Indy Hematology Review Presentation Archive 2021 MULTIPLE MYELOMA: THE CURE AROUND THE CORNER – Kenneth Anderson, MD STATE OF THE ART: 2021 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu Ejedafeta Birhiray, MD TREATMENT OF RELAPSED/ REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA IN 2021: THE CHESON APPROACH – Bruce D. Cheson, M.D., FACP, FAAAS, FASCO HEMATOPOIETIC STEM CELL TRANSPLANTATION: UPDATING THE OLD CLOSET – Richard Childs, M.D ACUTE MYELOID LEUKEMIA: FINALLY, A TRIP BEYOND 7+3 – Harry Erba, MD ACUTE LYMPHOBLASTIC LEUKEMIA: BIOLOGIC AND TARGETED THERAPY – Hagop M. Kantarjian, MD BENIGN HEMATOLOGY: CLOTTING, BLEEDING AND MORE – Craig Kessler, MD CHRONIC MYELOID LEUKEMIA: THERAPY UPDATED AND MODIFIED FOR 2021 – Richard Larson, MD AGGRESSIVE B AND T CELL LYMPHOMAS: EMERGING THERAPIES – John Leonard, MD MYELOPROLIFERATIVE NEOPLASMS: RISK STRATIFICATION AND THERAPY; A 2021 GLOBAL PERCEPTIVE – Ruben Mesa, MD, FACP INDOLENT AND MANTLE CELL LYMPHOMA: UPDATING THE TOOLBOX, INCLUDING AND BEYOND ANTI-CD20 ANTIBODIES – Sonali M. Smith, MD MYELODYSPLASTIC SYNDROME: EMERGING AND TARGETED THERAPIES – Richard Stone, MD MASTOCYTOSIS AND EOSINOPHILIA: THE VEXING DISORDERS OF THE BLOOD – Ayalew Tefferi, MD WALDENSTRÖM’S MACROGLOBULINEMIA: TARGETING FOR THE BIG KILL – Steven Treon, MD, MA, PhD, FACP, FRCP CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP CHRONIC LYMPHOCYTIC LEUKEMIA: CURABILITY AND DURATION OF THERAPY – Jennifer Woyach, MD
